Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01220921 · ClinicalTrials.gov registry record · Phase 3
Neurosurgery Patient Outcomes in Treating Spinal Disorders
A Phase 3 study of Symptomatic Lumbar Disc Herniation and Symptomatic Grade I Lumbar Spondylolisthesis, sponsored by Greenwich Hospital.
- Completed
- Registry status
- Phase 3
- Development phase
- 198
- Enrollment target
- 13
- Study locations
NCT01220921: Completed Phase 3 study of Symptomatic Lumbar Disc Herniation and Symptomatic Grade I Lumbar Spondylolisthesis, sponsored by Greenwich Hospital.
NCT01220921 is a Phase 3 study of Symptomatic Lumbar Disc Herniation and Symptomatic Grade I Lumbar Spondylolisthesis that has completed, run by Greenwich Hospital. The registered enrollment target is 198 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (74% lower). The trial reports 13 study locations across 12 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01220921, a Phase 3 study of Symptomatic Lumbar Disc Herniation and Symptomatic Grade I Lumbar Spondylolisthesis, has completed, sponsored by Greenwich Hospital.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 198 participants
- Enrollment target
- 13
- Study locations
Study Summary
The creation of a multi-center cooperative research group encompassing academic and community-based spinal practices . . .
Primary Outcome
Health-realted quality of life outcome measure
Conditions Studied
Interventions
- PROCEDURE Lumbar Discectomy
- PROCEDURE Single-level lumbar fusion
Study Locations (13)
Connecticut
- Greenwich Hospital - Greenwich
- Yale New Haven Hospital - New Haven
California
- University of California - San Francisco - San Francisco
Maryland
- Johns Hopkins Hospital - Baltimore
Massachusetts
- Lahey Clinic - Burlington
New Jersey
- University of Medicine and Dentistry - New Jersey - Newark
New York
- Columbia University - Neurological Institute - New York
North Carolina
- Carolina Spine - Charlotte
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 198 participants |
| Start Date | 2010-09 |
| Est. Completion | 2012-09 |
| Phase | Phase 3 |
What the finished NCT01220921 record still lists
NCT01220921 is an interventional study that assigns participants to a tested intervention. The registered 198 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (74% lower).
The record links to 2 conditions, with Symptomatic Lumbar Disc Herniation appearing as the primary indexed condition, and to 2 interventions - of which Lumbar Discectomy is the first listed.
NCT01220921 lists 13 locations in 12 states (Connecticut, California, Maryland).
Frequently Asked Questions
What is clinical trial NCT01220921 about?
NCT01220921 is a clinical study titled "Neurosurgery Patient Outcomes in Treating Spinal Disorders". The creation of a multi-center cooperative research group encompassing academic and community-based spinal practices . . .
What is the current status of trial NCT01220921?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 198 participants. The study started on 2010-09. Estimated completion is 2012-09.
What conditions does trial NCT01220921 study?
This clinical trial studies the following conditions: Symptomatic Lumbar Disc Herniation, Symptomatic Grade I Lumbar Spondylolisthesis.
What interventions are being tested in trial NCT01220921?
The interventions under investigation include: Lumbar Discectomy (PROCEDURE), Single-level lumbar fusion (PROCEDURE).
Who is sponsoring clinical trial NCT01220921?
This trial is sponsored by Greenwich Hospital, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01220921 being conducted?
This trial has 13 study locations across California, Connecticut, Maryland, Massachusetts, New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01220921's enrollment target sits among peer trials
198 1389th of 2000 higher than 611 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05203328 · 198 participants · NA
Prospective Study to Evaluate High Flow Nasal Cannula With Monitored Anesthesia Care During EBUS Bronchoscopy
- NCT05426967 · 198 participants · NA
rTMS for Military TBI-related Depression
- NCT05561114 · 198 participants · Phase 3
Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Esophagus
- NCT05585190 · 198 participants · NA
Stand Up for Your Health with a Sit-stand Desk
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia